| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.643 | 0.006 | 0.643 | 5 Hydroxytryptamine release inhibitor | 0.534 0.023 CID_33761 | ||
| 0.597 | 0.019 | 0.597 | Aldehyde oxidase inhibitor | 0.294 0.068 CID_33761 | ||
| 0.48 | 0.017 | 0.48 | Cardiotonic | 0.386 0.031 CID_33761 | ||
| 0.475 | 0.012 | 0.475 | Sigma receptor agonist | 0.154 0.083 CID_33761 | ||
| 0.434 | 0.005 | 0.434 | Tyrosine 3 hydroxylase inhibitor | 0.322 0.024 CID_33761 | ||
| 0.43 | 0.005 | 0.43 | Anesthetic local | 0.299 0.013 CID_33761 | ||
| 0.443 | 0.032 | 0.443 | Spasmolytic | 0.305 0.068 CID_33761 | ||
| 0.359 | 0.004 | 0.359 | Potassium channel (Ca-activated) activator | 0.267 0.007 CID_33761 | ||
| 0.345 | 0.011 | 0.345 | 5 Hydroxytryptamine 1E antagonist | 0.28 0.045 CID_33761 | ||
| 0.32 | 0.002 | 0.32 | 5 Hydroxytryptamine 4 antagonist | 0.215 0.003 CID_33761 | ||
| 0.377 | 0.072 | 0.421 | GABA C receptor rho-3 antagonist | 0.421 0.053 CID_33761 | CID_33761 | |
| 0.319 | 0.029 | 0.319 | MAP kinase kinase 2 inhibitor | 0.275 0.044 CID_33761 | ||
| 0.32 | 0.038 | 0.32 | Psychostimulant | 0.305 0.041 CID_33761 | ||
| 0.315 | 0.046 | 0.315 | Superoxide dismutase inhibitor | 0.227 0.091 CID_33761 | ||
| 0.275 | 0.011 | 0.275 | Alpha 2b adrenoreceptor antagonist | 0.267 0.012 CID_33761 | ||
| 0.28 | 0.017 | 0.31 | Nitric-oxide synthase stimulant | 0.31 0.009 CID_33761 | CID_33761 | |
| 0.263 | 0.004 | 0.263 | Acetylcholine release stimulant | 0.175 0.007 CID_33761 | ||
| 0.257 | 0.01 | 0.34 | 5 Hydroxytryptamine agonist | 0.34 0.007 CID_33761 | CID_33761 | |
| 0.278 | 0.032 | 0.278 | Neuropeptide Y2 antagonist | 0.232 0.074 CID_33761 | ||
| 0.313 | 0.079 | 0.313 | Calcium channel activator | 0.304 0.088 CID_33761 | ||
| 0.235 | 0.005 | 0.235 | Potassium channel large-conductance Ca-activated activator | 0.204 0.006 CID_33761 | ||
| 0.331 | 0.109 | 0.331 | Histamine release inhibitor | 0.226 0.175 CID_33761 | ||
| 0.233 | 0.025 | 0.233 | Nav1.2 sodium channel blocker | 0.122 0.081 CID_33761 | ||
| 0.232 | 0.026 | 0.279 | Heat shock protein 90 antagonist | 0.279 0.014 CID_33761 | CID_33761 | |
| 0.291 | 0.099 | 0.291 | Transcription factor NF kappa B inhibitor | 0.255 0.124 CID_33761 | ||
| 0.195 | 0.026 | 0.195 | Nav1.3 sodium channel blocker | 0.186 0.03 CID_33761 | ||
| 0.21 | 0.048 | 0.21 | Tumour necrosis factor antagonist | 0.175 0.072 CID_33761 | ||
| 0.185 | 0.025 | 0.185 | Cyclooxygenase 3 inhibitor | 0.155 0.044 CID_33761 | ||
| 0.185 | 0.027 | 0.185 | Chelator | 0.11 0.065 CID_33761 | ||
| 0.187 | 0.037 | 0.187 | Acetylcholinesterase inhibitor | 0.156 0.052 CID_33761 | ||
| 0.208 | 0.063 | 0.208 | Focal adhesion kinase 2 inhibitor | 0.15 0.131 CID_33761 | ||
| 0.142 | 0.002 | 0.142 | 5 Hydroxytryptamine 4 agonist | 0.125 0.002 CID_33761 | ||
| 0.261 | 0.123 | 0.282 | Vasodilator, coronary | 0.282 0.103 CID_33761 | CID_33761 | |
| 0.19 | 0.055 | 0.255 | Heat shock protein 90 alpha antagonist | 0.255 0.025 CID_33761 | CID_33761 | |
| 0.178 | 0.044 | 0.238 | GABA C receptor rho-2 antagonist | 0.238 0.014 CID_33761 | CID_33761 | |
| 0.207 | 0.074 | 0.207 | Amyloid beta aggregation inhibitor | 0.179 0.089 CID_33761 | ||
| 0.168 | 0.036 | 0.168 | DNA intercalator | |||
| 0.214 | 0.083 | 0.214 | Peptidyltransferase inhibitor | 0.197 0.103 CID_33761 | ||
| 0.191 | 0.062 | 0.191 | Lipocortins synthesis antagonist | |||
| 0.157 | 0.032 | 0.157 | Butyrylcholinesterase inhibitor | 0.118 0.048 CID_33761 | ||
| 0.13 | 0.012 | 0.13 | 5 Hydroxytryptamine 3 antagonist | 0.097 0.018 CID_33761 | ||
| 0.175 | 0.059 | 0.175 | Cholinergic | 0.134 0.091 CID_33761 | ||
| 0.149 | 0.033 | 0.149 | Alpha 2c adrenoreceptor antagonist | 0.143 0.036 CID_33761 | ||
| 0.146 | 0.032 | 0.188 | Carbonic anhydrase XV inhibitor | 0.188 0.021 CID_33761 | CID_33761 | |
| 0.12 | 0.007 | 0.127 | Heat shock protein 90 beta antagonist | 0.127 0.006 CID_33761 | CID_33761 | |
| 0.202 | 0.089 | 0.202 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.137 | 0.025 | 0.137 | Electrolyte absorption antagonist | 0.109 0.047 CID_33761 | ||
| 0.206 | 0.096 | 0.211 | Antiamyloidogenic | 0.211 0.093 CID_33761 | CID_33761 | |
| 0.263 | 0.154 | 0.305 | 15-Lipoxygenase inhibitor | 0.305 0.129 CID_33761 | CID_33761 | |
| 0.136 | 0.028 | 0.136 | Folate antagonist | 0.13 0.032 CID_33761 | ||
| 0.121 | 0.019 | 0.144 | Myeloperoxidase inhibitor | 0.144 0.012 CID_33761 | CID_33761 | |
| 0.106 | 0.006 | 0.106 | Epithelial sodium channel blocker | 0.092 0.009 CID_33761 | ||
| 0.174 | 0.075 | 0.177 | MAP kinase kinase 5 inhibitor | 0.177 0.068 CID_33761 | CID_33761 | |
| 0.2 | 0.1 | 0.2 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.192 0.105 CID_33761 | ||
| 0.185 | 0.088 | 0.185 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.173 0.103 CID_33761 | ||
| 0.165 | 0.069 | 0.169 | Interleukin 6 antagonist | 0.169 0.065 CID_33761 | CID_33761 | |
| 0.192 | 0.098 | 0.192 | ErbB-1 antagonist | |||
| 0.167 | 0.073 | 0.167 | Src kinase inhibitor | 0.144 0.088 CID_33761 | ||
| 0.132 | 0.038 | 0.132 | Platelet activating factor alpha antagonist | 0.095 0.063 CID_33761 | ||
| 0.102 | 0.015 | 0.102 | 5 Hydroxytryptamine 3A antagonist | 0.09 0.023 CID_33761 | ||
| 0.213 | 0.128 | 0.282 | 5 Hydroxytryptamine uptake stimulant | 0.282 0.055 CID_33761 | CID_33761 | |
| 0.163 | 0.079 | 0.163 | Catenin beta inhibitor | |||
| 0.087 | 0.006 | 0.087 | Ryanodine receptor antagonist | 0.07 0.017 CID_33761 | ||
| 0.201 | 0.12 | 0.229 | MAP kinase kinase 3 inhibitor | 0.229 0.057 CID_33761 | CID_33761 | |
| 0.287 | 0.209 | 0.287 | Caspase 9 stimulant | |||
| 0.119 | 0.042 | 0.119 | Sphingomyelinase inhibitor | 0.085 0.079 CID_33761 | ||
| 0.229 | 0.164 | 0.296 | Calpain 2 inhibitor | 0.296 0.117 CID_33761 | CID_33761 | |
| 0.166 | 0.104 | 0.166 | DNA methylase inhibitor | |||
| 0.122 | 0.062 | 0.122 | Platelet activating factor antagonist | |||
| 0.165 | 0.104 | 0.165 | I kappa B kinase epsilon inhibitor | |||
| 0.092 | 0.036 | 0.097 | Estrogen-related receptor beta agonist | 0.097 0.028 CID_33761 | CID_33761 | |
| 0.072 | 0.016 | 0.072 | Topoisomerase II beta inhibitor | |||
| 0.111 | 0.055 | 0.114 | Urease inhibitor | 0.114 0.051 CID_33761 | CID_33761 | |
| 0.069 | 0.013 | 0.069 | Sodium/calcium exchanger inhibitor | 0.066 0.015 CID_33761 | ||
| 0.159 | 0.104 | 0.159 | Non-steroidal antiinflammatory agent | 0.145 0.122 CID_33761 | ||
| 0.143 | 0.088 | 0.161 | CF transmembrane conductance regulator agonist | 0.161 0.058 CID_33761 | CID_33761 | |
| 0.153 | 0.099 | 0.153 | Death-associated protein kinase 2 inhibitor | |||
| 0.125 | 0.071 | 0.125 | c-Src kinase inhibitor | 0.106 0.085 CID_33761 | ||
| 0.152 | 0.099 | 0.166 | Amyloid beta precursor protein antagonist | 0.166 0.085 CID_33761 | CID_33761 | |
| 0.15 | 0.102 | 0.15 | ATPase inhibitor | 0.135 0.131 CID_33761 | ||
| 0.09 | 0.042 | 0.09 | Alpha 2a adrenoreceptor antagonist | 0.09 0.041 CID_33761 | ||
| 0.115 | 0.067 | 0.132 | 5 Hydroxytryptamine antagonist | 0.132 0.058 CID_33761 | CID_33761 | |
| 0.201 | 0.156 | 0.201 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.095 | 0.05 | 0.095 | NADH dehydrogenase inhibitor | |||
| 0.056 | 0.012 | 0.056 | 5 Hydroxytryptamine 3B antagonist | 0.043 0.019 CID_33761 | ||
| 0.197 | 0.154 | 0.197 | Gastrin inhibitor | |||
| 0.103 | 0.06 | 0.103 | Platelet activating factor beta antagonist | |||
| 0.124 | 0.082 | 0.124 | Lck kinase inhibitor | 0.108 0.094 CID_33761 | ||
| 0.112 | 0.069 | 0.112 | 5 Hydroxytryptamine 2B antagonist | 0.095 0.089 CID_33761 | ||
| 0.074 | 0.034 | 0.074 | Potassium channel (ATP-sensitive) blocker | 0.074 0.035 CID_33761 | ||
| 0.092 | 0.053 | 0.092 | Insulin growth factor antagonist | |||
| 0.188 | 0.151 | 0.191 | Transcription factor STAT3 inhibitor | 0.191 0.147 CID_33761 | CID_33761 | |
| 0.097 | 0.06 | 0.097 | Fibroblast growth factor 1 antagonist | 0.078 0.076 CID_33761 | ||
| 0.093 | 0.056 | 0.093 | Polo-like kinase-1 inhibitor | 0.085 0.071 CID_33761 | ||
| 0.087 | 0.052 | 0.087 | Insulin like growth factor 1 antagonist | |||
| 0.107 | 0.072 | 0.107 | Interleukin 2 antagonist | |||
| 0.086 | 0.051 | 0.086 | Platelet growth factor antagonist | |||
| 0.086 | 0.052 | 0.095 | D-Ala-D-Ala ligase inhibitor | 0.095 0.036 CID_33761 | CID_33761 | |
| 0.144 | 0.11 | 0.144 | DNA methyltransferase I inhibitor | |||
| 0.105 | 0.071 | 0.118 | Mucolytic | 0.118 0.057 CID_33761 | CID_33761 | |
| 0.066 | 0.034 | 0.072 | Corticotropin releasing factor 2 receptor antagonist | 0.072 0.025 CID_33761 | CID_33761 | |
| 0.097 | 0.065 | 0.138 | Glutamate (mGluR7) agonist | 0.138 0.017 CID_33761 | CID_33761 | |
| 0.075 | 0.043 | 0.075 | Phospholipase D inhibitor | |||
| 0.234 | 0.202 | 0.234 | DNA directed DNA polymerase inhibitor | |||
| 0.125 | 0.095 | 0.125 | Peroxidase inhibitor | 0.115 0.105 CID_33761 | ||
| 0.173 | 0.144 | 0.229 | Calpain inhibitor | 0.229 0.086 CID_33761 | CID_33761 | |
| 0.048 | 0.019 | 0.048 | Plasmepsin II inhibitor | |||
| 0.082 | 0.054 | 0.099 | Adrenaline agonist | 0.099 0.037 CID_33761 | CID_33761 | |
| 0.255 | 0.227 | 0.283 | MAP kinase 1 inhibitor | 0.283 0.199 CID_33761 | CID_33761 | |
| 0.048 | 0.021 | 0.053 | Dihydrofolate reductase inhibitor | 0.053 0.016 CID_33761 | CID_33761 | |
| 0.062 | 0.035 | 0.063 | Fibroblast growth factor 4 antagonist | 0.063 0.034 CID_33761 | CID_33761 | |
| 0.047 | 0.021 | 0.049 | Alpha 1L adrenoreceptor agonist | 0.049 0.018 CID_33761 | CID_33761 | |
| 0.145 | 0.12 | 0.145 | Anesthetic general | |||
| 0.065 | 0.041 | 0.065 | Dopamine D3 antagonist | 0.056 0.048 CID_33761 | ||
| 0.066 | 0.041 | 0.078 | Beta 3 adrenoreceptor antagonist | 0.078 0.025 CID_33761 | CID_33761 | |
| 0.088 | 0.066 | 0.102 | Glutamate release inhibitor | 0.102 0.039 CID_33761 | CID_33761 | |
| 0.072 | 0.051 | 0.072 | Telomerase inhibitor | |||
| 0.062 | 0.041 | 0.062 | Beta 2 adrenoreceptor agonist | 0.062 0.041 CID_33761 | ||
| 0.111 | 0.091 | 0.111 | Ca2+/calmodulin-dependent kinase II delta inhibitor | |||
| 0.059 | 0.041 | 0.063 | Gonadotropin-releasing hormone receptor agonist | 0.063 0.034 CID_33761 | CID_33761 | |
| 0.065 | 0.048 | 0.067 | Purinergic P2X2 antagonist | 0.067 0.047 CID_33761 | CID_33761 | |
| 0.092 | 0.075 | 0.138 | GABA C receptor rho-1 antagonist | 0.138 0.027 CID_33761 | CID_33761 | |
| 0.047 | 0.033 | 0.047 | CC chemokine 4 receptor antagonist | |||
| 0.183 | 0.17 | 0.183 | Thyroid hormone beta antagonist | |||
| 0.186 | 0.174 | 0.186 | Thyroid hormone antagonist | |||
| 0.198 | 0.187 | 0.198 | Beta lactamase inhibitor | |||
| 0.164 | 0.154 | 0.164 | Interleukin agonist | |||
| 0.034 | 0.025 | 0.034 | Phosphoglycerate kinase inhibitor | 0.033 0.026 CID_33761 | ||
| 0.02 | 0.01 | 0.02 | Estrogen-related receptor gamma agonist | |||
| 0.059 | 0.05 | 0.059 | Dopamine D2 antagonist | |||
| 0.045 | 0.038 | 0.045 | Benzodiazepine antagonist | |||
| 0.112 | 0.107 | 0.112 | Activin receptor-like kinase 2 inhibitor | |||
| 0.064 | 0.059 | 0.064 | Dopamine antagonist | |||
| 0.084 | 0.079 | 0.093 | MAP kinase kinase 1 inhibitor | 0.093 0.065 CID_33761 | CID_33761 | |
| 0.076 | 0.072 | 0.076 | Alpha 2 adrenoreceptor antagonist | |||
| 0.08 | 0.076 | 0.091 | Potassium channel activator | 0.091 0.06 CID_33761 | CID_33761 | |
| 0.065 | 0.066 | 0.07 | Topoisomerase II alpha inhibitor | 0.07 0.062 CID_33761 | CID_33761 | |
| 0.096 | 0.097 | 0.119 | CDK3/cyclin E inhibitor | 0.119 0.056 CID_33761 | CID_33761 | |
| 0.034 | 0.036 | 0.046 | Dihydropteroate synthase inhibitor | 0.046 0.02 CID_33761 | CID_33761 | |
| 0.068 | 0.071 | 0.075 | Potassium channel (Tandem pore domain) blocker | 0.075 0.049 CID_33761 | CID_33761 | |
| 0.014 | 0.019 | 0.015 | CDK2/cyclin A3 inhibitor | 0.015 0.014 CID_33761 | CID_33761 | |
| 0.119 | 0.126 | 0.144 | Neuropeptide Y1 antagonist | 0.144 0.075 CID_33761 | CID_33761 | |
| 0.062 | 0.07 | 0.089 | Nav1.8 sodium channel blocker | 0.089 0.035 CID_33761 | CID_33761 | |
| 0.104 | 0.115 | 0.115 | DNA repair enzyme inhibitor | 0.115 0.083 CID_33761 | CID_33761 | |
| 0.076 | 0.087 | 0.087 | Granulocyte macrophage colony stimulating factor agonist | 0.087 0.059 CID_33761 | CID_33761 | |
| 0.036 | 0.047 | 0.042 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.042 0.028 CID_33761 | CID_33761 | |
| 0.023 | 0.035 | 0.029 | Purinergic P2Y15 antagonist | 0.029 0.018 CID_33761 | CID_33761 | |
| 0.041 | 0.056 | 0.047 | Alpha tubulin antagonist | 0.047 0.044 CID_33761 | CID_33761 | |
| 0.077 | 0.097 | 0.089 | MAP kinase 8 inhibitor | 0.089 0.075 CID_33761 | CID_33761 | |
| 0.037 | 0.061 | 0.053 | Dopamine D4 agonist | 0.053 0.032 CID_33761 | CID_33761 | |
| 0.095 | 0.12 | 0.113 | Sodium channel blocker | 0.113 0.094 CID_33761 | CID_33761 | |
| 0.093 | 0.12 | 0.112 | Cytokine production inhibitor | 0.112 0.097 CID_33761 | CID_33761 | |
| 0.048 | 0.079 | 0.064 | Beta adrenoreceptor antagonist | 0.064 0.048 CID_33761 | CID_33761 | |
| 0.075 | 0.106 | 0.088 | Interleukin 1 beta converting enzyme inhibitor | 0.088 0.075 CID_33761 | CID_33761 | |
| 0.046 | 0.084 | 0.077 | Alpha adrenoreceptor agonist | 0.077 0.04 CID_33761 | CID_33761 | |
| 0.079 | 0.118 | 0.124 | GABA C receptor antagonist | 0.124 0.048 CID_33761 | CID_33761 | |
| 0.117 | 0.164 | 0.166 | Aryl hydrocarbon receptor agonist | 0.166 0.124 CID_33761 | CID_33761 | |
| 0.058 | 0.124 | 0.115 | Bronchodilator | 0.115 0.048 CID_33761 | CID_33761 | |
| 0.092 | 0.186 | 0.137 | Sphingosine 1-phosphate receptor 2 antagonist | 0.137 0.06 CID_33761 | CID_33761 | |
| 0.045 | 0.148 | 0.078 | Antiadrenergic | 0.078 0.073 CID_33761 | CID_33761 | |
| 0.123 | 0.242 | 0.251 | 5 Hydroxytryptamine release stimulant | 0.251 0.088 CID_33761 | CID_33761 | |
| 0.04 | 0.173 | 0.073 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.073 0.052 CID_33761 | CID_33761 | |
| 0.113 | 0.294 | 0.188 | DNA synthesis inhibitor | 0.188 0.141 CID_33761 | CID_33761 | |
| 0.021 | 0.257 | 0.069 | DNA gyrase inhibitor | 0.069 0.037 CID_33761 | CID_33761 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |